Infographic | October 15, 2024

The Future Of Filling: Addressing The Challenges Of Late-Stage Manufacturing With Aseptic Filling Solutions

Source: Cytiva
Aseptic Filling

With a goal of developing standardized aseptic filling technologies that are optimal for today’s advanced therapies, Cytiva is seeking to define what “optimal” really means. To gain insights, the current landscape of filling and late-stage manufacturing was examined to identify both risks and opportunities for improvement. 78 professionals were consulted from top biopharmaceutical, biotechnology, contract manufacturing, and cell and gene therapy or personalized medicine companies to better understand the limitations, needs, and risks they face in producing next-generation treatments. Keep reading to hear what they said about the challenges of late-stage manufacturing.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online